TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)

Clinical trial NCT03247309 · COMPLETED

Trial details

NCT number: NCT03247309
Sponsor: Immatics US, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Cancer Recurrent Solid Tumors Refractory Solid Tumors

Start date: 2018-12-19
Primary completion: 2023-04-20
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.